Primary Peritoneal Carcinoma Completed Phase 1 Trials for Docetaxel (DB01248)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00066456Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube CancerTreatment